SCHEMBL5049186

SCHEMBL5049186

CCCCNC(=O)Oc1cc(-c2csc(-c3ccc(OC)cc3)n2)n(Cc2ccccc2)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 3/20 0.41
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
KMT2A Q03164 1/20 0.41
RELA Q04206 1/20 0.41
ATM Q13315 1/20 0.41
ALOX5 P09917 1/20 0.41
MGLL Q99685 1/20 0.41
ATP4A P20648 1/20 0.40
ATP4B P51164 1/20 0.40
EIF4E P06730 1/20 0.39
GAA P10253 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039689 0.96 MAPT (0.43) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5044045 0.93 THRB (0.45) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5046059 0.91 EIF4E (0.46) MAPTTP53MGLLATP4AATP4B
SCHEMBL5048718 0.91 EIF4E (0.41) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5046039 0.91 CYP3A4 (0.41) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5043715 0.87 HPGD (0.50) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5048696 0.85 CDC25A (0.43) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5046060 0.84 KLKB1 (0.43) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5046032 0.83 KLKB1 (0.53) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5044042 0.82 CDC25A (0.42) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed